Ugur Sahin, M.D., Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel ...
CHARLESTON, S.C. (WCSC) - The Trump administration started to cut funding from messenger ribonucleic acid vaccine research earlier this month, impacting more than 20 contracts for vaccine development.
Foundation-funded project targets infectious bronchitis and infectious laryngotracheitis viruses.
Hosted on MSN
Albumin-recruiting lipid nanoparticles could make future mRNA vaccines safer and more effective
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most active stocks to buy according to analysts. On June 13, Ethris announced a collaboration with Thermo Fisher Scientific. The partnership aims ...
RFK Jr., secretary of Health and Human Services, has canceled $500 million of mRNA research funding. The development of the mRNA vaccine is what allowed our country to move out of the COVID-19 ...
CureVac Continues to Burn Cash; Provides Very Risk-Tolerant Investors With Exposure to mRNA Pipeline
CureVac was founded in 2000, and its focus is on developing vaccines and therapies using messenger ribonucleic acid, or mRNA. mRNA offers several advantages, including cell-free, rapid, large-scale ...
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback